¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"In Vitro Cell Dev Biol"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
myeloma cell
°ñ¼öÁ¾¼¼Æ÷
myoepithelial cell
±Ù(À°)»óÇǼ¼Æ÷
myoid cell
±Ù(À°)À¯»ç¼¼Æ÷
mantle cell lymphoma
¿ÜÅõ¼¼Æ÷¸²ÇÁÁ¾
marrow cell
°ñ¼ö¼¼Æ÷
mast cell
ºñ¸¸¼¼Æ÷
mast cell degranulation
ºñ¸¸¼¼Æ÷Å»°ú¸³
mast cell disease
ºñ¸¸¼¼Æ÷º´
mastoid air cell
²ÀÁö¹úÁý, À¯µ¹¹úÁý
matrix cell
¹ÙÅÁÁú¼¼Æ÷, ±âÁú¼¼Æ÷
memory B cell
±â¾ïB¼¼Æ÷
memory cell
¸é¿ª±â¾ï¼¼Æ÷
memory T cell
±â¾ïT¼¼Æ÷
Merkel cell-neurite complex
¸Þ¸£Ä̼¼Æ÷½Å°æµ¹±âº¹ÇÕ, Ã˰¢¼¼Æ÷½Å°æµ¹±âº¹ÇÕü
mesangial cell
Ç÷°ü»çÀ̼¼Æ÷, ¸Þ»êÁö¿ò¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
polynucleated cell
¹µÇÙ¼¼Æ÷
prickle cell
°¡½Ã¼¼Æ÷
primed cell
ÃÊȸ°¨ÀÛ¼¼Æ÷
primordial germ cell
¿ø½ÃÁ¾ÀÚ¼¼Æ÷
principal cell
ÁÖ¼¼Æ÷
Purkinje cell
½ÉÀåÀüµµ±ÙÀ°¼¼Æ÷, Á¶·Õ¹Ú¼¼Æ÷
pyramidal cell
ÇǶó¹Ô¼¼Æ÷
receptor cell
¼ö¿ëü¼¼Æ÷
red blood cell
ÀûÇ÷±¸
reserve cell
¿¹ºñ¼¼Æ÷
residential cell
Á¤ÁÖ¼¼Æ÷
resting cell
ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
reticular cell
±×¹°¼¼Æ÷
reticuloendothelial cell
±×¹°³»ÇǼ¼Æ÷, ¼¼¸Á³»ÇǼ¼Æ÷
reticulum cell
(¢¡reticular cell) ±×¹°¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
hypercomplex cell
Ãʺ¹ÇÕ¼¼Æ÷(õ±ÜÜùêá¬øà)
hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
IIÇü
hypersensitivity reactions,type iv(cell-mediated)
IVÇü
hypersensitivity, cell-mediated
¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
hypersensitized cell
°ú°¨ÀÛ¼¼Æ÷.
hypoglycemia, beta cell tumor
ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
hypoxic cell
Àú»ê¼Ò¼¼Æ÷
hypoxic cell sensitizer
Àú»ê¼Ò¼¼Æ÷°¨ÀÛÁ¦
i-cell disease
I-¼¼Æ÷º´
idiotype specific regulatory cell
°³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
immortalized cell
¹«ÇÑÁõ½Ä¼¼Æ÷
immunity,cell-mediated
¼¼Æ÷¸Å°³¼º(á¬øàØÚË¿àõ)
immunocompetent cell
¸é¿ªÀû°Ý¼¼Æ÷.
immunodeficiency syndrome, cell mediated
¼¼Æ÷¸Å°³ ¸é¿ª°áÇÌ ÁõÈıº
immunologically committed cell
¸é¿ª°æÇè¼¼Æ÷(¡ÌèúÐá¬øà).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
cell, giant
°Å´ë¼¼Æ÷
cell, helper
Á¶·Â¼¼Æ÷, º¸Á¶¼¼Æ÷
cell, hybrid
ÇÏÀ̺긮µå¼¼Æ÷
cell, immunocompetent
¸é¿ª´É¼¼Æ÷
cell, inflammatory
¿°Áõ¼¼Æ÷
cell, killer
»ìÇØ¼¼Æ÷
cell, memory
±â¾ï¼¼Æ÷
cell, natural killer
ÀÚ¿¬»ìÇØ¼¼Æ÷, NK¼¼Æ÷
cell, nonpermissive
ºñÇã¿ë¼¼Æ÷, Áõ½ÄºÒÇã¼¼Æ÷
cell, null
¹«Ç¥Áö¼¼Æ÷
cell, permissive
Áõ½ÄÇã¿ë¼¼Æ÷
cell, plaque-forming
ÇöóÅ© Çü¼º¼¼Æ÷
cell, precursor
Àü±¸¼¼Æ÷
cell, primed T
ÃÊȸ°¨ÀÛ T¼¼Æ÷
cell, pyroninophilic blast
ÇǷδѻê ģȾƼ¼Æ÷
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½